Your browser doesn't support javascript.
loading
A Computational Platform Integrating a Mechanistic Model of Crohn's Disease for Predicting Temporal Progression of Mucosal Damage and Healing.
Venkatapurapu, Sai Phanindra; Iwakiri, Ryuichi; Udagawa, Eri; Patidar, Nikhil; Qi, Zhen; Takayama, Ryoko; Kumar, Kei; Sato, Yuki; Behar, Marcelo; Offner, Patrick; Dwivedi, Gaurav; Miyasaka, Haruna; Suzuki, Ryohsuke Ken; Hamada, Anna Lissa; D'Alessandro, Paul M; Fernandez, Jovelle.
Afiliação
  • Venkatapurapu SP; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA. sai.phanindra.venkatapurapu@pwc.com.
  • Iwakiri R; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Udagawa E; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Patidar N; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Qi Z; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Takayama R; PwC Consulting LLC, Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Kumar K; PwC Consulting LLC, Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Sato Y; PwC Consulting LLC, Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Behar M; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Offner P; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Dwivedi G; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Miyasaka H; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Suzuki RK; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Hamada AL; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • D'Alessandro PM; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Fernandez J; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Adv Ther ; 39(7): 3225-3247, 2022 07.
Article em En | MEDLINE | ID: mdl-35581423
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article